相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis
Yasutaka Yamada et al.
JOURNAL OF HUMAN GENETICS (2018)
Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea
Sang-Wook Yi et al.
CANCER (2018)
Novel approaches for molecular targeted therapy against hepatocellular carcinoma
Yuji Eso et al.
HEPATOLOGY RESEARCH (2018)
Hypoxia Mediates Mitochondrial Biogenesis in Hepatocellular Carcinoma to Promote Tumor Growth Through HMGB1 and TLR9 Interaction
Samer Tohme et al.
HEPATOLOGY (2017)
Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation
Rejina Afrin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma
Guixiang Lv et al.
LIVER INTERNATIONAL (2017)
FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer
Lingfeng He et al.
MOLECULAR ONCOLOGY (2017)
HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway
Zheying Zhang et al.
PLOS ONE (2017)
Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma
Deyuan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis
Shuzhen Chen et al.
CANCER LETTERS (2017)
Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer
Miroslava Jurikova et al.
ACTA HISTOCHEMICA (2016)
MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3
Xiunan Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
A. Blythe Ryerson et al.
CANCER (2016)
MicroRNA-505 suppresses proliferation and invasion in hepatoma cells by directly targeting high-mobility group box 1
Lin Lu et al.
LIFE SCIENCES (2016)
Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells
Shengnan Guo et al.
MEDICAL SCIENCE MONITOR (2016)
Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
Joerg Trojan et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2016)
High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells
Raymond Reeves
DNA REPAIR (2015)
Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients
Minghui Li et al.
TUMOR BIOLOGY (2015)
HMGB3 characterization in gastric cancer
Y. Gong et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Tumor Suppressive Function of mir-205 in Breast Cancer Is Linked to HMGB3 Regulation
Ola A. Elgamal et al.
PLOS ONE (2013)
Prognostic value of HMGB3 expression in patients with non-small cell lung cancer
Ning Song et al.
TUMOR BIOLOGY (2013)
Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation
Xiao-Di Yan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Upregulation of Cyclin B1 by miRNA and its implications in cancer
Vera Huang et al.
NUCLEIC ACIDS RESEARCH (2012)
High-mobility group box family of proteins: ligand and sensor for innate immunity
Hideyuki Yanai et al.
TRENDS IN IMMUNOLOGY (2012)
High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma
Hua-Rong Tang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
HMGB proteins and transcriptional regulation
Tetsuya Ueda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
HMGNs, DNA repair and cancer
Gabi Gerlitz
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
HMGB proteins: Interactions with DNA and chromatin
Michal Stros
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
HMGA and Cancer
Monica Fedele et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Overexpression of High-Mobility Group Box 2 Is Associated with Tumor Aggressiveness and Prognosis of Hepatocellular Carcinoma
Jung-Hee Kwon et al.
CLINICAL CANCER RESEARCH (2010)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Recombination hot spot of hepatitis B virus genome binds to members of the HMG domain protein family and the Y box binding protein family; Implication of these proteins in genomic instability
K Kajino et al.
INTERVIROLOGY (2001)
分享论文
